Primer: Transcenta (6628 HK) - Aug 2026
Transcenta is a high-risk, high-reward clinical-stage biopharmaceutical company, with its valuation contingent on the success of its...
92 Views
𝛼SK or SearchENTITY
Transcenta (6628 HK)
Transcenta (6628 HK)
17
Analysis
Health Care • China
Transcenta is a clinical-stage biopharmaceutical company with integrated capabilities in the discovery, research, development, manufacturing, and business development of biopharmaceuticals. The company develops therapeutic antibody molecules for oncology and selected non-oncology indications, including bone and kidney disorders, and also provides contract development and manufacturing organization (CDMO) services. Transcenta is headquartered in Suzhou, China, and was founded in 2010.
morex